Amikacin for treatment of infections in patients with malignant diseases.
about
Pulmonary infections in immunocompromised children.Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever.Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients.Factors associated with nephrotoxicity and clinical outcome in patients receiving amikacin.Reappraisal of guidelines for pharmacokinetic monitoring of aminoglycosides.Circadian variation in serum amikacin levels.
P2860
Amikacin for treatment of infections in patients with malignant diseases.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh-hant
name
Amikacin for treatment of infections in patients with malignant diseases.
@en
Amikacin for treatment of infections in patients with malignant diseases.
@nl
type
label
Amikacin for treatment of infections in patients with malignant diseases.
@en
Amikacin for treatment of infections in patients with malignant diseases.
@nl
prefLabel
Amikacin for treatment of infections in patients with malignant diseases.
@en
Amikacin for treatment of infections in patients with malignant diseases.
@nl
P2093
P1476
Amikacin for treatment of infections in patients with malignant diseases.
@en
P2093
P304
P356
10.1093/INFDIS/135.SUPPLEMENT_2.S421
P407
P478
P577
1976-11-01T00:00:00Z